BBLG - Bone Biologics Corp

1.35
-0.055   -4.074%

Share volume: 14,504
Last Updated: 04-23-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$1.40
-0.05
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 35%
Dept financing 22%
Liquidity 50%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-2.17%
1 Month
18.42%
3 Months
-21.51%
6 Months
-39.73%
1 Year
97.72%
2 Year
-11.48%
Key data
Stock price
$1.35
P/E Ratio 
0.00
DAY RANGE
$1.35 - $1.38
EPS 
-$4.39
52 WEEK RANGE
$0.63 - $6.75
52 WEEK CHANGE
$98.50
MARKET CAP 
7.930 M
YIELD 
N/A
SHARES OUTSTANDING 
1.795 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
1.74
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$11,305
AVERAGE 30 VOLUME 
$12,046
Company detail
CEO: Jeffrey Frelick
Region: US
Website: bonebiologics.com
Employees: 2
IPO year: 2026
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.

Recent news